Timolol after myocardial infarction: an answer or a new set of questions?
- 16 May 1981
- Vol. 282 (6276) , 1565-1570
- https://doi.org/10.1136/bmj.282.6276.1565
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- ANTICOAGULANTS IN CORONARY HEART DISEASE—RETROSPECT AND PROSPECTThe Lancet, 1981
- The FDA's Critique of the Anturane Reinfarction TrialNew England Journal of Medicine, 1980
- EARLY INTRAVENOUS ATENOLOL TREATMENT IN SUSPECTED ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1980
- Secondary prevention of myocardial infarction--the present state of the ART.BMJ, 1980
- Platelet-release reaction in myocardial infarction.BMJ, 1980
- EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1979
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978
- Assessment of antithrombotic agents: effects of dipyridamole analogues on platelet behaviourCardiovascular Research, 1972
- ABSENCE OF PROPHYLACTIC EFFECT OF PROPRANOLOL IN MYOCARDIAL INFARCTIONThe Lancet, 1966
- EFFECT OF PROPRANOLOL IN MYOCARDIAL INFARCTIONThe Lancet, 1965